FDA Import Refusal 1FX-3387421-4/10002/1 — IBSA Pharma SAS
The FDA refused shipment 1FX-3387421-4/10002/1 from IBSA Pharma SAS (France) on June 17, 2026. The refused product falls under Drugs and Biologics — HYALURONIDASE. Cited charges: 9999978,9999979,9999982 This firm has 1 other import refusal on record.
Refusal Details
- Date
- June 17, 2026
- Country
- France
- Product Category
- Drugs and Biologics
- Product Code
- 58IIO22 HYALURONIDASE
- Charges
- 9999978,9999979,9999982